Coronary artery disease
Drug research and approvals for coronary artery disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 1,248 studies of coronary artery disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 6 authorised medicines for it.
- Recruiting worldwide: 1,248
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 6
Recruiting Now
Newest start dates first, of 1,248 recruiting on ClinicalTrials.gov ↗- ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic…NCT07696533 · Not applicable · London North West Healthcare NHS Trust · starts Jul 3, 2027
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine,…NCT07083557 · Not reported · Bettina Mittendorfer · starts Jan 1, 2027
- Prognostic Value of Oxygen-15 Water PET in Coronary Artery DiseaseNCT07932314 · Phase 3 · Vastra Gotaland Region · starts Dec 1, 2026
- Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionNCT06217120 · Phase 2 · Montreal Heart Institute · starts Nov 6, 2026
- Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass SurgeryNCT07898215 · Not reported · Adiyaman University · starts Nov 4, 2026
- BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac RehabilitationNCT07741396 · Not applicable · University of Illinois Chicago · starts Nov 2, 2026
- Computational μFR-Guided Versus Angiographic Guidance in Drug-Coated Balloon AngioplastyNCT07917234 · Not applicable · Centro Cardiologico Monzino · starts Nov 1, 2026
- Implementation, Safety, and Effectiveness of Outpatient Cardiac Telerehabilitation in Patients With Ischemic Heart…NCT07927829 · Not applicable · Lithuanian University of Health Sciences · starts Nov 1, 2026
- Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary LesionsNCT07491107 · Not reported · Scitech Produtos Medicos SA · starts Oct 30, 2026
- A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery…NCT07357675 · Phase 3 · EBI Anti Sepsis BV · starts Oct 29, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Jul 20, 2023 | A phase 3, multicenter, open label study to confirm the diagnostic potential of intravenously administered 15o-h2o to identify coronary artery disease during…[15O]-H2O FOR INJECTION | MEDTRACE PHARMA A/S | Closed |
| Jul 6, 2022 | A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IIIb study evaluating the effect of inclisiran on atherosclerotic plaque…INCLISIRAN (KJX839) | Novartis Pharmaceuticals Corporation | Ongoing |
| Jun 7, 2019 | A phase 3, open-label, multicentre study of flurpiridaz (18f) injection for positron emission tomography (pet) imaging for assessment of myocardial perfusion…FLURPIRIDAZ (18F) INJECTION | GE | Closed |
| Dec 19, 2017 | A multi-center, double-blind, randomized, placebo-controlled study to assess the pharmacodynamics, pharmacokinetics, tolerability, and safety of a single…ACT-246475 | IDORSIA PHARMACEUTICALS LTD | Closed |
| Dec 18, 2014 | A phase 2, randomized, double-blind, placebo controlled, parallel study of gs-6615 in subjects with chronic stable angina and coronary artery diseaseGS-6615 | Gilead Sciences | Pending |
Medicines Authorised in the EU
Newest first| May 22, 2017 | Ivabradine Accordivabradine · generic | Accord Healthcare S.L.U. | EMA ↗ |
| Nov 11, 2016 | Ivabradine Zentivaivabradine · generic | Zentiva k.s. | EMA ↗ |
| Sep 8, 2015 | Ivabradine Anpharmivabradine | "Anpharm" Przedsiębiorstwo Farmaceutyczne S.A. | EMA ↗ |
| Mar 23, 2015 | Kengrexalcangrelor | Chiesi Farmaceutici S.p.A. | EMA ↗ |
| Oct 25, 2005 | Corlentorivabradine | Les Laboratoires Servier | EMA ↗ |
| Oct 25, 2005 | Procoralanivabradine | Les Laboratoires Servier | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA